Bendeka Interactions
There are 284 drugs known to interact with Bendeka (bendamustine), along with 4 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 48 are major, and 236 are moderate.
- View all 284 medications that may interact with Bendeka
- View Bendeka alcohol/food interactions (1)
- View Bendeka disease interactions (4)
Most frequently checked interactions
View interaction reports for Bendeka (bendamustine) and the medicines listed below.
- abacavir
- Abraxane (paclitaxel protein-bound)
- Adderall XR (amphetamine / dextroamphetamine)
- Adriamycin (doxorubicin)
- Aggrastat (tirofiban)
- allopurinol
- aluminum hydroxide / magnesium trisilicate
- ascorbic acid
- BeneFix (coagulation factor ix)
- bevacizumab
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Blenoxane (bleomycin)
- bleomycin
- Bosulif (bosutinib)
- bupropion
- BuSpar (buspirone)
- carboplatin
- carvedilol
- Cayston (aztreonam)
- chlordiazepoxide
- cisplatin
- Coreg (carvedilol)
- Cotellic (cobimetinib)
- Cytoxan (cyclophosphamide)
- Cytoxan Lyophilized (cyclophosphamide)
- Dacogen (decitabine)
- Rebinyn (coagulation factor ix)
- Rituxan (rituximab)
- Rituxan Hycela (hyaluronidase / rituximab)
- Sandimmune (cyclosporine)
Bendeka alcohol/food interactions
There is 1 alcohol/food interaction with Bendeka (bendamustine).
Bendeka disease interactions
There are 4 disease interactions with Bendeka (bendamustine) which include:
Report options
QR code containing a link to this page
More about Bendeka (bendamustine)
- Bendeka consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: alkylating agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
